Browsed by
Month: June 2021

FITCI & Betamore Expand Founder City Pitch Competition Deadline Extended & Final Celebration Moved to Fall 2021

FITCI & Betamore Expand Founder City Pitch Competition Deadline Extended & Final Celebration Moved to Fall 2021

Founder City, a hybrid conference-event, expanded weekly programming into June and extended its venture capital pitch competition deadline to September 17, which is open to all Maryland-based startups. Early applicants get mentor-ship & feedback from leading professionals, essential as a foundation for future fundraising. Registrants also get free access to Thumbraise, the app-based video pitch platform where they can polish a pitch for investors, get feedback, and gain visibility on a national level. Pitch finalists will present LIVE, on-stage at the finale celebration event. ...  Read more

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

FREDERICK, Md.June 16, 2021 /PRNewswire/ — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the closing of a $16.6 million Series A financing.  The round was led by Hatteras Venture Partners with participation from Genesys Capital, Point Field Partners and Alexandria Venture Investments as well as support from previous Veralox investors including Sanofi Ventures, JDRF T1D Fund, Maryland Momentum Fund, VTC Innovation Fund and TEDCO.  The Company also announced that Ben Scruggs, PhD, principal at Hatteras Venture Partners, and Jamie Stiff, MBA, managing director at Genesys Capital, will join the Veralox Therapeutics board of directors. ...  Read more